CAPTRUST FINANCIAL ADVISORS - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$36,000
-16.3%
2,597
+17.4%
0.00%
Q1 2022$43,0000.0%2,213
-16.9%
0.00%
Q4 2021$43,000
-17.3%
2,662
+42.0%
0.00%
Q3 2021$52,000
-7.1%
1,8740.0%0.00%
-100.0%
Q2 2021$56,000
-15.2%
1,874
-21.1%
0.00%0.0%
Q1 2021$66,000
+34.7%
2,374
+36.3%
0.00%0.0%
Q4 2020$49,000
+11.4%
1,7420.0%0.00%0.0%
Q3 2020$44,0000.0%1,7420.0%0.00%0.0%
Q2 2020$44,000
+1366.7%
1,742
+771.0%
0.00%
Q3 2019$3,0000.0%2000.0%0.00%
Q2 2019$3,0000.0%2000.0%0.00%
Q1 2019$3,000
-25.0%
2000.0%0.00%
Q4 2018$4,000
-20.0%
2000.0%0.00%
Q3 2018$5,0000.0%2000.0%0.00%
Q2 2018$5,000
-16.7%
2000.0%0.00%
Q1 2018$6,000
-14.3%
2000.0%0.00%
Q4 2017$7,000
+16.7%
2000.0%0.00%
Q3 2017$6,0002000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders